Latest Investigation News

LTR Pharma’s intranasal spray OROFLOW® has secured ethics approval for a clinical study targeting oesophageal motility disorders, marking its first foray beyond erectile dysfunction. The study, led by Dr Peter Wu, aims to validate a non-invasive alternative for swallowing difficulties in a market projected to reach US$8.1 billion by 2034.

AFT Pharmaceuticals surged 22% to NZ$254.7 million revenue in FY26, surpassing profit guidance and securing FDA approval to advance a pivotal injectable iron Phase III trial targeting a $7.4 billion market. The company is poised for further global expansion and product launches in FY27.

Viva Energy has brought its Residue Catalytic Cracking Unit back online at the Geelong Refinery, pushing production to over 90% capacity following a fire in April. However, the Alkylation unit remains offline and is expected to be out of action throughout 2027.

Basin Energy's maiden drilling at Newmans Prospect outlines a 3.3 km corridor of magnet rare earth mineralisation, validating a preserved-weathering exploration model and identifying two priority target zones for follow-up.

Unico Silver’s latest drilling at the Joaquin Project in Argentina has delivered standout high-grade gold-silver intercepts outside the March 2026 Mineral Resource Estimate, underpinning potential resource growth ahead of the Pre-Feasibility Study.

Jindalee Lithium’s US subsidiary, HiTech Minerals, has partnered with environmental nonprofit RESOLVE to investigate a voluntary stewardship area around its McDermitt Lithium Project, aiming to balance responsible lithium development with conservation efforts.

FIN Resources has landed a C$111,034 government grant to expand its geophysical surveys at the Cabin Lake Gold Project in Canada’s Northwest Territories, aiming to sharpen drill targets and unlock further exploration potential.

Actinogen Medical’s pivotal XanaMIA Alzheimer’s trial has passed a third independent safety review, endorsing continuation without changes. Final topline efficacy data is expected in November 2026.

VBX Limited has secured key environmental approvals that reduce the Wuudagu bauxite project footprint by nearly 10% while allowing mining rates up to 9 Mtpa. The project advances with a finalized Environmental Review Document and ongoing Definitive Feasibility Study, promising significant community and economic benefits.

Stelar Metals has completed its initial fieldwork at the Hill of Leaders Tungsten Project, confirming broad tungsten mineralisation and setting the stage for drilling campaigns starting in July.

Delta Lithium Limited has acquired key tenements at its Yinnetharra Project, gaining full control over 170 km2 of lithium prospective ground. The company also reports a notable gold occurrence at Mason’s prospect and continues extensive exploration across its large tenure.

Paradigm Biopharmaceuticals has completed enrolment ahead of schedule in its pivotal Phase 3 trial for Zilosul®, enrolling 538 patients with knee osteoarthritis and maintaining its timeline for interim and final results.